Although cultured astrocytes express functional glutamate receptors, they are generally resistant to excitotoxic cell death. We explored the role of receptor desensitization in glutamatemediated astrocyte injury. In cultures of type 1 astrocytes from mouse neocortex, brief application of AMPA evoked small, rapidly desensitizing inward currents, whereas kainate evoked small, sustained currents. Neither agonist increased cytosolic calcium, and astrocyte toxicity occurred only after 24 hr exposure to high (500-1000 PM) concentrations of kainate but not to AMPA or glutamate.
Cyclothiazide, a drug that selectively blocks AMPA receptor desensitization, greatly potentiated AMPA-or kainate-gated currents and intracellular calcium elevation. Coapplication of lo-100 PM cyclothiazide with glutamate, AMPA, or kainate produced widespread astrocyte cell death within 2 hr of application. The enhancement of toxicity by cyclothiazide, which alone was not toxic, was concentration-dependent for each of the tested agonists (EC, , and was blocked by further addition of the selective AMPAIkainate antagonist 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX). NMDA caused no injury even in the presence of cyclothiazide. Cyclothiazide-enhanced injury varied with the age of astrocyte cultures; the maximal effect occurred at -2 weeks in vitro, and little death was seen after 4 weeks. Type 1 astrocytes express AMPA-type glutamate receptors that are unmasked by reducing their desensitization with cyclothiazide.
Although overactivation of AMPA receptors can be rapidly lethal to astrocytes, rapid desensitization normally limits this toxicity. The extent of AMPA receptor desensitization may be an important determinant of glial vulnerability to excitotoxic insults.
Key words: astrocytes; glutamate; glutamate receptors; desensitization; cell death; calcium; Fura-2; electrophysiology; cyclothiazide; cell culture Cell death produced by excessive glutamate receptor activation, or excitotoxicity, is an important mechanism of neuronal injury associated with cerebral hypoxia-ischemia and other acute brain insults. It is not known whether similar mechanisms can also contribute to glial cell death in this setting. Glial cells express various membrane channels and ligand-gated receptors, including those for glutamate (see Barres, 1991; Hosli and Hosli, 1993) . In vitro models of excitotoxic injury have consistently demonstrated a rapidly triggered neuronal cell death caused by glutamate activation of NMDA receptors and a more slowly developing excitotoxicity mediated by non-NMDA [R,Sa-amino-3-hydroxy-5methylisoxazole-4-propionic acid/kainate (AMPAI kainate)] receptors (Choi, 1992) . Although astrocytes do not express NMDA receptors (Kettenmann and Schachner, 1985) and would not be expected to be vulnerable to rapidly triggered NMDA toxicity, they do have functional non-NMDA ionotropic receptors. Therefore, it is interesting that direct ionotropic glutamate receptor activation is not toxic to cultured astrocytes. For example, in primary hippocampal or cortical cultures, glia survive exposures to glutamate, NMDA, or AMPA at concentrations sufficient to destroy almost all neurons (Rothman, 1984; Choi et al., 1987; Koh et al., 1990) .
Several explanations may account for the relative resistance of cultured astrocytes to glutamate-mediated toxicity. Astrocytes may express few glutamate receptors, their glutamate receptors may be functionally different from neuronal glutamate receptors, or they may lack the intracellular processes that are operative in neurons to link glutamate receptor activation to cell death. We have explored the hypothesis that glutamate receptor desensitization influences glial vulnerability. Non-NMDA receptor-linked channels are characterized by desensitization despite the continued presence of agonist (Zorumski and Thio, 1992) and receptor subtypes can be distinguished by the rate and pharmacology of this desensitization. AMPA receptors exhibit rapidly desensitizing currents with AMPA application and more sustained currents with kainate application. The currents produced by both agonists are markedly potentiated by drugs such as cyclothiazide, which blocks AMPA receptor desensitization (Yamada and Tang, 1993; Patneau et al., 1993) . In contrast, kainate receptors exhibit desensitizing currents with kainate agonists (Huettner, 1990 ) but their desensitization is unaffected by cyclothiazide (Wong and Mayer, 1993) . Reducing desensitization with plant lectins or thiazides enhances AMPA/kainate-mediated excitotoxicity in cultured neurons (Zorumski et al., 1990; May and Robison, 1993; Moudy et al., 1994) and potentiates neuronal injury after deprivation of oxygen and glucose in cortical cultures (Probert and Marcoux, 1993; Bateman et al., 1993) .
The physiological, molecular, and pharmacological characterization of glial non-NMDA glutamate receptors is less complete. Cyclothiazide potentiates whole-cell currents evoked by AMPA in glial cells of O-2A lineage Holzwarth et al., in Cultured Astrocytes J. Neurosci., January 1, 1996, 76(1):200-209 201 1994), which includes type 2 astrocytes and oligodendroglia (Raff et al., 1983) . However, the effects of cyclothiazide on type 1 astrocyte AMPA-or kainate-evoked responses have not been described. The goal of the present studies was to assess a potential role of AMPA receptor desensitization in limiting excitotoxic injury to cultured type l-like astrocytes derived from fetal mouse neocortex. Preliminary reports have appeared in abstract form (David et al., 1995a,b) .
MATERIALS AND METHODS
Cell culture. Cortical astrocyte cultures were prepared from neonatal Swiss-Webster mice (l-3 d postnatal) as previously described (Rose et al., 1993; Goldberg and Choi, 1993) . Dissociated astrocytes were plated in media containing 10% equine serum, 10% fetal bovine serum, and epidermal growth factor (10 @ml) at a density of 0.05 hemispheres/ml into 24 well multiwell plates (Primaria, Falcon, Bedford, MA) or at 0.2 hemispheres/ml into 35 mm dishes with glass coverslip bottoms (MatTek, Ashland, MA) coated with poly-D-lysine (Sigma, St. Louis, MO) and laminin (Collaborative Research, Bedford, MA). Cultures were maintained in a 5% CO,-humidified incubator at 37°C.
Immunocytochemistry.
Astrocyte cultures were fixed in 4% p-formaldehyde in PBS, permeabilized as needed for 10 min in 0.25% Triton X-100, and then incubated for 1 hr in 10% normal goat serum (NGS). Cultures were incubated at room temperature for 2 hr with one of the following antibodies in PBS containing>% NGS: rabbit polyclonal antibody to glid fibrillarv acidic protein (GFAP: 1:l as supplied; Incstar, Stillwater, MN), mouse *monocldnal antibody to the A25 antigen (not permeabilized; 1:lOO; Boehringer Mannheim, Indianapolis, IN), mouse monoclonal antibody to galactocerebroside (not permeabilized, 1:20; Boehringer Mannheim), or mouse monoclonal antibody to the microtubule-associated protein (MAP-2 1:400; Boehringer Mannheim). After washing, cultures were exposed for 1 hr to the appropriate goat Cy3-conjugated secondary antibody (1:lOO; Jackson Immunoresearch, West Grove, PA) at room temperature for 30 min. Cells were examined under epifluorescence illumination on a Nikon Diaphot inverted microscope.
Electroohvsioloev.
Established elial cell cultures 14-16 d in vitro were resuspended in gyowth medium &d plated at low density onto 35 mm plastic dishes. Whole-cell recordings were performed on single cells 2-6 hr after replating at room temperature on the stage of an inverted microscone. Growth medium was renlaced bv an external recording solution that contained 140 InM NaCl, 3.0 mM KCl, 1.0 mM MgCl,, 2.0 rnG CaCl,. 10 mM HEPES. and 10 mu/l ohenol red. oH 7.3. The internal recording solution contained 130-rnh CsCl, ld ' mM TEACl, 10 mM HEPES, 1.1 mM EGTA, and 5.5 mM glucose, pH 7.2. AMPA and kainate were dissolved directly into the external recording solution or were made from aqueous stock solutions. Stock solutions of cyclothiazide were prepared in dimethyl sulfoxide (DMSO) and diluted in recording buffer; the final DMSO concentration was 0.1% by volume. Patch electrodes were pulled in three stages (Sutter Instruments, Novato, CA) and had DC resistances of 5-10 Ma. These electrodes were connected to a patch amplifier in voltage-clamp mode using the whole-cell configuration (Hamill et al., 1981) . Approximately 60-80% of the series resistance was compensated for. The holding potential was -60 mV, unless indicated otherwise.
Continuous perfusion of the dish with drug-free recording solution was accomplished via gravity flow at a rate of 2-3 ml/min. The recorded cell was also locally perfused via a large-bore fused silica-quartz tube (internal diameter 320 pm) connected to four separate reservoirs, each with a separate solenoid valve to control its flow. Only one of the four valves could be opened at a time. AMPA or kainate was applied via a second flow tube, also connected individually to four separate reservoirs. Agonist was applied by simultaneously switching off the local wash reservoir and opening the agonist reservoir. Flow occurred via gravity. Steady-state currents were used for comparison and were defined as the averaged current during a 30 msec interval at the end of the 300 msec agonist application.
Measurement of cytosolic calcium. Astrocyte cultures were loaded with the acetoxymethyl ester of the cytosolic calcium indicator 4 pM Fura- (Grynkiewicz et al., 1985) in a HEPES-buffered salt solution containing 116 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO,, 1.01 rnM NaH,PO,, 25 mM NaHCO,, 12 mM HEPES, 5.5 mM n-glucose, 1.8 mM CaCl,, and 10 mg/l phenol red, pH 7.4, for 30 min at room temperature and were incubated after washing for an additional 30 min to allow intracellular conversion to free Fura-2. Cultures were then placed on the stage of a Nikon Diaphot inverted microscope. Cells were examined under epifluorescence illumination using a 75 W xenon source, computer-controlled shutter and alternating 340 2 10 and 380 2 10 nm excitation filters, 400 nm dichroic mirror, 510 nm emission filter, and a 40X oil-immersion objective (NA 1.3, Nikon). The emitted images obtained at 5-45 set intervals were acquired with an intensified charge-coupled device low-light camera (Hamamatsu Photonics, Oak Brook, IL) and digitized using an imageprocessing system (MetaFluor, Universal Imaging, West Chester, PA).
Regions of interest were selected from phase-contrast videomicrographs before the experimental treatment, and 340/380 nm excitation ratios [proportional to cytosolic calcium concentration ([Ca"li)] were calculated after background subtraction for each region. Experimental compounds were delivered by bath perfusion. ]Ca*+]; values were calibrated by comparison with low and high calciumsolutions (Grynkiewicz et al., 1985) containing 50 tiM free Fura-and imaged in glass microslides with 20 $r pathlength (Vitro Dynamics, Rockaway, NT).
Excitatory amino acid exposure. Astrocyte cultures were rinsed with serum-free Minimal Essential Medium (Gibco, Grand Island, NY) (modified by the addition of glucose, total 25.5 ITIM, and the omission of glutamine) containing the experimental reagents and were incubated for 22-26 hr in a 5% CO,-humidified incubator at 37°C. Cell damage was assessed by observation at 200-400X with phase-contrast optics. Loss of astrocyte viability was confirmed by incubating cultures with the fluorescent dye propidium iodide at 1 pg/ml for lo-20 min and by examining cultures under green epifluorescence. Videomicroscope images were acquired under phase-contrast or epifluorescence optics using a siliconintensified target camera (Hamamatsu) and were digitized using a PCbased image analysis system (MetaMorph, Universal Imaging, Boston, MA). Cell death was assessed quantitatively by measurement of lactate dehydrogenase (LDH) released to the exposure medium 20-28 hr after the beginning of agonist exuosure (Koh and Choi. 1987) . Values were expressed relitive t'; LDH measurements from sister cultures maximally destroyed by 1 hr exposure to the calcium ionophore, 10 pM ionomycin (= loo), after subtraction of the small amount of LDH present in control cultures exposed only to wash conditions (=O). Each experiment was performed on sister cultures of a single plating and was representative of more than three similar experiments performed on different cultures. Statistical significance was assessed by analysis of variance and StudentNewman-Keuls test.
Reagents. Stock solutions of the applied drugs were made at least 100X concentrated in Minimal Essential -Medium-or distilled water, except cvclothiazide. which was dissolved in DMSO (10 mMk RS-AMPA and NBQX were' provided by Parke-Davis Laboratories (Ann Arbor, MI), and cyclothiazide was provided by Eli Lilly Research Laboratories (Indianapolis, IN). Most other drugs and reagents were purchased from Sigma.
RESULTS
Characterization of cortical glial cultures Dissociated cultures prepared from postnatal mouse neocortex consisted mostly of thin, polygonal cells (see Figs. 2-4). The culture surface was confluent by 2 weeks in vitro. As previously noted , a vast majority of these cells (>9.5%) were labeled with antibodies to GFAP. These flat cells were not labeled with antibodies to A2B.5, galactocerebroside (gal-C), or MAP-2, which recognize type 2 astrocytes/O-2A progenitor cells, oligodendrocytes, and neurons, respectively (data not shown). The pattern of immunocytochemical labeling is consistent with the designation of these glial cells as type l-like astrocytes (Raff et al., 1983) .
AMPA and kainate receptor currents in cultured astrocytes Whole-cell currents gated by glutamate agonists were examined in type 1 astrocytes. Because maintenance of adequate voltageclamp in monolayer astrocyte cultures was difficult because of electrotonic coupling between cells, monolayer cultures were dissociated by addition of trypsin and EGTA and replated at low applied alone for 300 msec produced small, barely detectable inward currents (the AMPA current exhibits desensitization; see insets). B, Cyclothiazide (CYZ) (100 pM) markedly potentiated both AMPA and kainate currents. C, AMPA and kainate currents were blocked by 10 PM NBQX. Calibration bars are the same for A-C. D, A different cortical astrocyte stepped to holding potentials between -90 and + 90 mV at 20 mV increments. At each holding potential, 300 pM kainate was applied in the presence of 100 pM cyclothiazide for 300 msec. The steadystate current was averaged between the two arrows and plotted versus the holding potential. Kainate alone produced small currents (data not shown), and the I/V relationship exhibited reversal near 0 mV with strong outward rectification (circles). In 100 WM cyclothiazide, the current amplitudes were larger, but the reversal potential remained near 0 mV and the outward rectification was reduced (squares). every cell in which a detectable current was observed (n = 8) and in four cells in which no detectable current was observed. The range of enhancement was 5.1-284 times the control steady-state current (this wide range was largely attributable to the difficulty of accurately assessing the very small control steady-state currents).
Six of 18 cells did not respond to AMPA even in the presence of cyclothiazide. Kainate -I cyclothiazide was applied to 14 cells; in 10 of 14 cells kainate produced sustained currents, which were potentiated by cyclothiazide to 1.8-19.8 times the control steadystate current. In 4 of 14 cells there was no response to kainate even with cyclothiazide. In 7 of 24 cells, both AMPA and kainate t cyclothiazide, were applied; there were no cells in which one agonist produced a current when the other did not. Figure L4 -C shows a representative example of a cell in which both AMPA and kainate produced barely detectable currents, which were markedly potentiated by cyclothiazide and blocked by further addition of 2,3-dioxo-6-nitro-7-sulfamoylbenzo( f)quinoxaline (NBQX), a selective competitive AMPA/ kainate antagonist. When the external solution was changed to one containing no added magnesium and 20 PM glycine, 300 PM NMDA failed to activate a detectable current, and voltage steps from -60 to 0 mV failed to activate rapid inward sodium currents (data not shown). These latter observations indicate that type 1 astrocytes do not possess NMDA receptors or high threshold, rapidly inactivating voltage-gated sodium conductances. In a few cells the current-voltage (I/V) relationship for AMPA/kainate-activated currents was examined. Without cyclothiazide, the I/V relationship was roughly linear, exhibiting outward rectification and a reversal potential near 0 mV, although the currents were usually small. In cyclothiazide, the slope-conductance was increased, but the reversal potential remained near 0 mV and outward rectification was reduced (Fig. 10) . These changes in the I/V relationship are similar to those observed in native neuronal AMPA/kainate receptors with cyclothiazide (Yamada and Tang, 1993) . Ionic currents observed in the present study were attributable to specific activation of ionotropic non-NMDA glutamate receptors rather than to glutamate uptake; they were induced by the selective agonists AMPA or kainate and were blocked by the competitive non-NMDA antagonist NBQX. Because desensitization occurred within milliseconds of AMPA application, it probably would not be observed without rapid drug perfusion and electrical isolation of astrocytes. It is likely that kainate currents also partially desensitized but that this occurred too rapidly to be detected with whole-cell recording. Cyclothiazide increased peak inward currents in response to both AMPA and kainate, revealing responses even in cells for which no current was recorded after application of AMPA alone. Perhaps more significantly, the cyclothiazide-enhanced currents were sustained for the duration of PM AMPA alone (C), and 100 FM AMPA and 100 FM cyclothiazidc (U). Pseudocolor images are shown using an intensity-modulated display (Tsien and Harootunian, 1990) , in which the hues represent the 3401380 ratio (red = high calcium), and the brlghtncss is proportional to the average brightness of the 340 and 380 nm images. Scale bar, 160 km. agonist application, resulting in a substantial amplification of the steady-state current.
[Ca"], Using Fura-fluorescence ratio imaging, resting [Cazili was low (-50-100 nM) and increased minimally in most astrocytes after transient application of l-300 FM AMPA (Fig. 2) . Application of cyclothiazide alone (100 FM) did not result in [Ca2~+li elevation. However, application of 100 PM AMPA together with 100 PM cyclothiazide resulted in a large increase in [Ca"+], (Fig. 2 ). In the presence of 100 PM cyclothiazide, the effect of AMPA was concentration-dependent, with little [Ca2+li elevation at 10 PM and near-maximal peak responses at 100-300 PM. Similar enhancement of [Ca'~'], elevation occurred when cyclothiazide was administered with loo-500 PM glutamate or kainate (data not shown).
Effect of cyclothiazide on toxicity of glutamate agonists We next examined the vulnerability to glutamate agonist application of cortical type 1 astrocytes maintained in primary culture for 1-3 weeks. Continuous exposure of the astrocyte monolayers to wash conditions or to glutamate, NMDA, or AMPA (up to 500 PM) resulted in no apparent change in phase-contrast appcarancc after 24 hr (Fig. 3A-D) or 48 hr (not shown). In contrast, exposure to 500 FM or 1 mM kainate resulted in a gradual degeneration of astrocytes (Fig. 3E,F) . This change was associated with loss of viability of a proportion of cells (typically less than half), as assessed by propidium iodide nuclear fluorescence.
We considered the possibility that the lack of toxicity of glutamate or AMPA, compared with kainate, would reflect the observed rapid complete desensitization after AMPA application. To test this hypothesis, we added cyclothiazide during exposures to the glutamate receptor agonists. In the added presence of 100 PM cyclothiazide, AMPA (500 PM), kainate (1 mM), and glutamate (500 FM) were rapidly toxic to the cultured astrocytes. This toxicity was apparent within l-2 hr under phase-contrast optics (Fig. 4&C) as a loss of distinct cell boundaries and the appearance of darkened borders surrounding the nuclei. In the subsequent hours, astrocytic nuclei became pyknotic, the cytosol acquired a granular appearance, and many cells detached from the ceil surface. The detached cells and most of the remaining cells were not viable, as assessed by a failure to exclude the vital dyes trypan blue or propidium iodide (Fig. 40) .
The morphological appearance of cell death was accompanied by release of LDH into the bathing medium. Because l-2 hr exposure to the calcium ionophore ionomycin (10 PM) resulted in the death of all cultured glia, this measurement was used as a comparison for all LDH measurements. A small amount of LDH was present in cultures exposed only to wash conditions; this was not significantly increased by 24 hr exposures to 500 FM AMPA alone (Fig. 4E) . Twenty-four hour exposures to 1 mM kainate alone did result in significant increases in LDH release (Fig. 4E) . However, extracellular LDH began to accumulate only after 8 hr of continuous kainate exposure. In the presence of 100 PM cyclothiazide, both 500 PM AMPA and 1 mM kainate resulted in substantial LDH release within the first 2 hr (Fig. 4E) . Most cells could be injured even by transient, 1 hr exposure to 500 PM AMPA or 1 mM kainate together with 100 FM cyclothiazide, followed by 24 hr incubation in drug-free medium. The addition Figure 3 . Excitatory amino acid toxicity in cultured cortical astrocytes. Sister cultures of primary astrocyte cultures were exposed to wash (A), 500 pM glutamate (B), 500 pM NMDA (C), 500 pM AMPA (D), 500 pM kainate (E), or 1 mM kainate (F) for 24 hr. Panels show phase-contrast videomicrographs (gray) superimposed with propidium iodide fluorescence staining (red) to indicate nonviable cells. Astrocyte death was observed only with prolonged &pbsurei to k'ainate. Scale bar, 100 pm.
-. , of NMDA did not cause an increase in LDH release in the presence or absence of cyclothiazide (Fig. 5) . The plant lectin concanavalin A (Con A) enhances currents of kainate-preferring glutamate receptors but not of AMPA receptors (Mayer and Vyklicky, 1989; Huettner, 1990) . Experiments with this agent were limited because 24 hr exposure to Con A (l-5 PM) caused the astrocytes to separate from the monolayer and to take on a rounded phase-bright appearance. However, exposure to 3 PM Con A alone did not result in a loss of viability, as assessed by LDH release or vital dye staining. Because it has been reported that Con A and glucose can compete for lectin-binding sites (Goldstein et al., 1965) , we performed these experiments in both low (0.5 mM, Fig. 6 ) and normal glucose concentrations (5 mM, data not shown) with similar results. In contrast to cyclothiazide, Con A did not significantly potentiate glial toxicity produced by 500 FM AMPA (Fig. 6) . Con A increased the toxicity of 1 mM kainate but to a lesser extent than cyclothiazide, and the addition of 30 pM NBQX significantly attenuated kainate toxicity enhanced by Con A (Fig. 6 ). This result supports the idea that cyclothiazide potentiation of AMPA toxicity is mediated by AMPA-preferring glutamate receptors. However, given the small enhancement of kainate-induced injury by Con A, we cannot exclude the possibility that kainate receptors also mediate toxicity.
The toxicity of 24 hr exposures to glutamate, AMPA, or kainate in the presence of cyclothiazide was dependent on agonist concentrations in the micromolar range (Fig. 7B-C) and could be attenuated by addition of 30 PM NBQX (Fig. 5) . The EC,,, for each of the agonists with 100 pM cyclothiazide was -30-100 PM. The cyclothiazide potentiation of AMPA neurotoxicity was concentration-dependent in the lo-100 FM range (Fig. 7A) . Even in the presence of saturating concentrations of both cyclothiazide and glutamate agonists, cell death and corresponding LDH release did not become maximal, indicating that some glial cells were resistant to this insult even though they could be killed by ionomycin.
The results described above were from cultures used within l-3 weeks from the day of plating (see Materials and Methods). The toxicity of cyclothiazide with glutamate receptor agonists varied with the age of the astrocyte cultures. The response to 100 PM cyclothiazide with either SO0 PM AMPA or 1 mM kainate was maximal in cultures at -2 weeks in vitro but became negligible in most cultures 4 weeks or older (Fig. 8) . It remains to be determined whether the observed developmental changes reflect alterations in glutamate receptor expression or in astrocyte resistance to receptor-mediated insults. DISCUSSION Astrocytes in vivo (Martin et al., 1993; Matute et al., 1994) and in vitro (Condorelli et al., 1993) express AMPA/kainate receptor subunit proteins, and glutamate depolarizes astrocytes in primary culture (Bowman and Kimelberg, 1984; Kettenmann et al., 1984) and hippocampal slices (Walz and MacVicar, 1988) . However, the characterization of astrocytic AMPA and kainate receptors is incomplete, and the functional significance of glutamate receptor expression in glial cells is largely undefined. Glial cell type and cell type of origin influence the expression of AMPA/kainate receptors (Barres, 1991) . Glia can be divided according to a morphological and antigenic classification first proposed for the rat optic nerve (Raff, 1989) . Type 1 astrocytes develop from their own precursor cells, whereas type 2 astrocytes and oligodendrocytes develop from common precursors known as O-2A progenitor cells (Raff et al., 1983) . Non-NMDA glutamate receptor-linked ion channels have been characterized extensively in glial cells of the 02-A lineage both in vitro , 1990a,b; Wyllie et al., 1991; Patneau et al., 1994) and in vivo (Barres et al., 1990a,b; Berger et al., 1992) . In contrast, non-NMDA glutamate receptor-mediated responses are observed less consistently in type 1 astrocytes. Depolarizing responses have been shown in some cases to be mediated by electrogenic glutamate uptake (Barbour et al., 1988; Wyllie et al., 1991; Stephens et al., 1993) , and several investigators have observed small or, absent responses to selective non-NMDA receptor stimulation in type 1 astrocytes (Backus et al., 1989; Barres et al., 1990a) . However, other studies using selective agonists support the presence of glutamate receptor-linked ion channels (Sontheimer et al., 1988; Enkvist et al., 1989; Backus et al., 1989; Stephens et al., 1993) . Glia from murine neocortex were identified as type l-like astrocytes by phase-contrast appearance and antigenic profile. In agreement with other investigators (Backus et al., 1989; Barres et al., 1990a) , we found that application of AMPA or kainate alone induced small (~50 PA) or undetectable inward currents. Although such small responses are consistent with a paucity of functional receptors expressed by these cells, our data suggest an additional explanation: the presence of AMPA-induced electro-24 oped during 8-24 hr, whereas cyclothiazide combined with either AMPA or kainate produced widespread toxicity in the first 2 hr. physiological responses was masked by rapid receptor desensitization. In approximately two-thirds of astrocytes, cyclothiazide, a blocker of AMPA receptor desensitization, produced marked enhancement of AMPA-or kainate-induced currents.
Cultured astrocytes respond to glutamate with an elevation in [Caztli (Glaum et al., 1990; Jensen and Chiu, 1990; Cornell-Bell et al., 1992; Holzwarth et al., 1994; Porter and McCarthy, 1995) . In agreement with Jensen and Chiu (1991) , application of AMPA or kainate alone on type 1 astrocytes evoked minimal or no increases in [Cazili, even when these agonists were applied at high concentrations (500 WM). Cyclothiazide alone did not alter astrocyte [Ca'+] ,, but greatly enhanced [Ca'+] , elevation produced by AMPA, kainate, or glutamate. Although Ca'+-permeable AMPA receptors (Iino et al., 1990) have been described in Bergmann glia (Burnashev et al., 1992; Muller et al., 1992) and in some cells of the 0-2A lineage (Fulton et al., 1992; Holzwarth et al., 1994) , cyclothiazideenhanced [Ca'+] , elevation in the present experiments probably was not mediated by Ca'+-permeable AMPA receptors. The observed singly rectifying IN relationship in type 1 astrocytes (Fig. 10) suggests that GluRB (GluR2) is one of the subunits comprising the channels responsible for these ionic currents and predict that these channels have low Ca*' permeability (Hollmann et al., 1991) . Cyclothiazide did not result in AMPA-induced [Ca*+], elevation in the absence of extracellular sodium (our unpublished data), suggesting that intracellular Ca*+ accumulation occurred only by indirect pathways, potentially including reversed operation of the Na+/Ca*+ exchanger. Brief exposures to glutamate or to glutamate agonists alone are sufficient to destroy CNS neurons in many culture systems. However, although selective activation of glutamate receptors induces a number of morphological and biochemical alterations in astrocytes (Koh et al., 1990; Noble et al., 1992; Sun et al., 1992) , such treatments do not lead to astrocyte cell death (Rothman, 1984; Choi et al., 1987; Koh et al., 1990; Bridges et al., 1992) . Glutamate-mediated toxicity has been observed in a few forms of glial injury. Haas and Erdo (1991) reported that astrocytes maintained in serum-free conditions could be injured by 24 hr exposures to quisqualate but not kainate, leading these authors to propose a role for metabotropic receptormediated injury. Oka et al. (1993) found that cultured oligodendrocytes were susceptible to prolonged glutamate exposure. This toxicity was not reproduced by selective agonists and seemed to involve glutamate uptake rather than receptor activation. In contrast, glial injury in the present experiments was associated with overactivation of ionotropic glutamate receptors. Prolonged exposure to 500 pM concentrations of glutamate, AMPA, and NMDA produced no injury. Although exposure to kainate caused astrocyte death, this toxicity was submaximal and occurred only when kainate was applied at very high concentrations (500 pM or 1 mM) for durations of many hours (16-24 hr). In the presence of cyclothiazide, otherwise sublethal concentrations of glutamate, AMPA, and kainate became highly toxic, producing extensive astrocyte degeneration within the first few hours of application. This dramatic effect was concentration-dependent for each of the agonists (EC,, 30-100 pM) and was abolished by the further addition of NBQX. These observations indicate that glial excitotoxic injury was mediated by overactivation of AMPA receptors. The ionic mechanisms of this injury remain to be established. AMPA receptor activation in the presence of cyclothiazide was associated with sustained elevation of intracellular Ca'+. As is true of neuronal excitotoxicity, both Ca'+-dependent and Ca*+ -independent mechanisms may potentially contribute to glial injury.
Several observations suggest that astrocyte glutamate receptors are dominated by AMPA-type subunits. In agreement with the observed results in astrocytes, AMPA-preferring non-NMDA glutamate receptors in central neurons are characterized by complete desensitization in the presence of glutamate or AMPA but only partial desensitization in the presence of kainate (see Zorumski and Thio, 1992) . The glial toxicity of kainate at high concentrations (without added cyclothiazide) but not of AMPA or glutamate may be attributable to the small but sustained currents evoked by kainate in these cells. In the present experiments, AMPA toxicity was enhanced by cyclothiazide but not by the lectin Con A. Cyclothiazide has been shown to selectively enhance responses of AMPA-but not kainate-preferring glutamate receptor subunits in isolated expression systems, whereas Con A is relatively selective for enhancement of kainate receptors (Partin et al., 1993; Patneau et al., 1994) . These types of responses to AMPA and kainate, including their potentiation by cyclothiazide, suggest that astrocyte glutamate receptors resemble native neuronal AMPA receptors. However, the state of AMPA receptor desensitization may play a more significant role in astrocytes than in neurons. In neurons, AMPA by itself induces readily measurable inward currents, [Ca2+li elevation, and slow toxicity, whereas these are all absent in astrocytes unless cyclothiazide is present. In the presence of cyclothiazide, AMPA-induced glial currents and [Ca2+Ji elevation were of almost the same magnitude (nA range) as those from cultured neurons under the same conditions (Yamada and Tang, 1993; Moudy et al., 1994) .
Relatively little is known about desensitization of astrocyte AMPA receptors in viva. Cultured astrocytes are known to differ from their in viva counterparts in many respects (Barres et al., 1990a) , and it is possible that cortical astrocytes are more susceptible to excitotoxic insults in vivo. For example, although isolated astrocytes are substantially less vulnerable than neurons to combined oxygen-glucose deprivation in cortical cultures (Callahan et al., 1990; Goldberg and Choi, 1993) both glia and neurons can be destroyed during cerebral infarction after focal ischemia. McDonald et al. (1992) observed that cortical and striatal injury (involving necrosis of all cell types) after intracerebral injection of AMPA was maximal at postnatal day 10 and subsequently declined during development. We are intrigued by the parallel time course of astrocyte vulnerability to AMPA-mediated cell death in culture ( Fig. 8 ) (see also Oka et al., 1993) . In addition to direct effects leading to cell death, astrocyte AMPA receptor stimulation may participate in injury indirectly by altering glial-glial (Dani et al., 1992; Jensen and Chiu, 1990; Cornell-Bell et al., 1992) or glial-neuronal (Mennerick and Zorumski, 1994; Nedergaard, 1994; Parpura et al., 1994) interactions. AMPA exposure triggers glutamate release from cortical astrocytes (Dugan et al., 199.5) , and this is greatly enhanced by the addition of cyclothiazide (David et al., 1995b) . Blockade of astrocyte AMPA receptors may contribute to the protective actions of AMPA antagonists in animal models of cerebral ischemia (Sheardown et al., 1990) .
Primary cell cultures allow examination of effects of glial AMPA receptors in isolation from effects on neurons. The cell culture model of cyclothiazide-enhanced glutamate toxicity may provide novel opportunities to study mechanisms of astrocyte vulnerability to excitotoxic insults. These observations raise the possibility that astrocyte injury during acute brain insults such as stroke or trauma is limited by the extent of AMPA receptor desensitization, and they suggest that pharmacological approaches to enhancing AMPA receptor desensitization will have therapeutic value.
